The patient was enrolled to the study on September 16, 2024 with the following diagnosis: hereditary painful pancreatitis (heterozygous mutation of the PRSS1 gene), continuously recurring disease form (7 or more attacks per year during the period from 2001 to 2024). This evidence concerns the gene PRSS1 and pancreatitis.